These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 35690956)
1. Impact of drug consumption rooms on non-fatal overdoses, abscesses and emergency department visits in people who inject drugs in France: results from the COSINUS cohort. Roux P; Jauffret-Roustide M; Donadille C; Briand Madrid L; Denis C; Célérier I; Chauvin C; Hamelin N; Maradan G; Carrieri MP; Protopopescu C; Lalanne L; Auriacombe M; Int J Epidemiol; 2023 Apr; 52(2):562-576. PubMed ID: 35690956 [TBL] [Abstract][Full Text] [Related]
2. Drug consumption rooms are effective to reduce at-risk practices associated with HIV/HCV infections among people who inject drugs: Results from the COSINUS cohort study. Lalanne L; Roux P; Donadille C; Briand Madrid L; Célerier I; Chauvin C; Hamelin N; Kervran C; Maradan G; Auriacombe M; Jauffret-Roustide M; Addiction; 2024 Jan; 119(1):180-199. PubMed ID: 37743675 [TBL] [Abstract][Full Text] [Related]
3. Impact of drug consumption rooms on risk practices and access to care in people who inject drugs in France: the COSINUS prospective cohort study protocol. Auriacombe M; Roux P; Briand Madrid L; Kirchherr S; Kervran C; Chauvin C; Gutowski M; Denis C; Carrieri MP; Lalanne L; Jauffret-Roustide M; BMJ Open; 2019 Feb; 9(2):e023683. PubMed ID: 30796121 [TBL] [Abstract][Full Text] [Related]
4. [Drug Consumption Rooms : Opinion and willingness among people who inject drugs in Marseille, France]. Briand Madrid L; Donadille C; Célerier I; Gutowski M; Grelli N; Maradan G; Jauffret-Roustide M; Lalanne L; Auriacombe M; Roux P; Rev Epidemiol Sante Publique; 2023 Feb; 71(1):101421. PubMed ID: 36571957 [TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of drug consumption rooms in France: a modelling study. Cousien A; Donadille C; Madrid LB; Maradan G; Jauffret-Roustide M; Lalanne L; Auriacombe M; Roux P; Boyer S BMC Public Health; 2024 May; 24(1):1426. PubMed ID: 38807111 [TBL] [Abstract][Full Text] [Related]
6. Drug consumption rooms in Catalonia: A comprehensive evaluation of social, health and harm reduction benefits. Folch C; Lorente N; Majó X; Parés-Badell O; Roca X; Brugal T; Roux P; Carrieri P; Colom J; Casabona J; Int J Drug Policy; 2018 Dec; 62():24-29. PubMed ID: 30352331 [TBL] [Abstract][Full Text] [Related]
7. Characteristics of persons who inject drugs and who witness opioid overdoses in Vietnam: a cross-sectional analysis to inform future overdose prevention programs. Blackburn NA; Lancaster KE; Ha TV; Latkin CA; Miller WC; Frangakis C; Chu VA; Sripaipan T; Quan VM; Minh NL; Vu PT; Go VF Harm Reduct J; 2017 Sep; 14(1):62. PubMed ID: 28882143 [TBL] [Abstract][Full Text] [Related]
8. Supervised injection facility use and all-cause mortality among people who inject drugs in Vancouver, Canada: A cohort study. Kennedy MC; Hayashi K; Milloy MJ; Wood E; Kerr T PLoS Med; 2019 Nov; 16(11):e1002964. PubMed ID: 31770391 [TBL] [Abstract][Full Text] [Related]
9. [Unsafe practices fostering cutaneous abscesses in people who inject substances : Results from the ANRS-OUTSIDER study]. Pereira Gonçalves J; Briand Madrid L; Donadille C; Michels D; Ahouah M; Rojas Castro D; Roux P Rev Epidemiol Sante Publique; 2023 Oct; 71(5):102142. PubMed ID: 37619302 [TBL] [Abstract][Full Text] [Related]
10. A qualitative study of how Danish drug consumption rooms influence health and well-being among people who use drugs. Kappel N; Toth E; Tegner J; Lauridsen S Harm Reduct J; 2016 Jun; 13(1):20. PubMed ID: 27306441 [TBL] [Abstract][Full Text] [Related]
11. Increased Uptake of HCV Testing through a Community-Based Educational Intervention in Difficult-to-Reach People Who Inject Drugs: Results from the ANRS-AERLI Study. Roux P; Rojas Castro D; Ndiaye K; Debrus M; Protopopescu C; Le Gall JM; Haas A; Mora M; Spire B; Suzan-Monti M; Carrieri P PLoS One; 2016; 11(6):e0157062. PubMed ID: 27294271 [TBL] [Abstract][Full Text] [Related]
12. Public injecting and its association with mental health and other drug-related outcomes among people who inject drugs in Iran. Khezri M; Tavakoli F; Karamouzian M; Sharifi H; Ghalehkhani N; Mousavian G; Mehmandoost S; Bazargani M; Hosseinpour AM; Mahboubi M; Baral S; Shokoohi M J Subst Abuse Treat; 2022 Dec; 143():108868. PubMed ID: 36137306 [TBL] [Abstract][Full Text] [Related]
13. The extent of and factors associated with self-reported overdose and self-reported receipt of naloxone among people who inject drugs (PWID) in England, Wales and Northern Ireland. O'Halloran C; Cullen K; Njoroge J; Jessop L; Smith J; Hope V; Ncube F Int J Drug Policy; 2017 Aug; 46():34-40. PubMed ID: 28586701 [TBL] [Abstract][Full Text] [Related]
14. Prescription opioid injection among young people who inject drugs in New York City: a mixed-methods description and associations with hepatitis C virus infection and overdose. Mateu-Gelabert P; Guarino H; Zibbell JE; Teubl J; Fong C; Goodbody E; Edlin B; Salvati C; Friedman SR Harm Reduct J; 2020 Mar; 17(1):22. PubMed ID: 32228700 [TBL] [Abstract][Full Text] [Related]
15. Prevalence and correlates of multiple non-fatal opioid overdoses among people who inject drugs who utilise needle syringe programs in Australia. Geddes L; Iversen J; Darke S; Dietze P; Maher L Int J Drug Policy; 2021 Oct; 96():103245. PubMed ID: 33840562 [TBL] [Abstract][Full Text] [Related]
16. Injecting Alone: Practices and Preferences among People Who Inject Drugs in New York City. Riback L; Pérez-Correa AE; Ghiroli MM; López-Castro T; Fox AD Subst Use Misuse; 2022; 57(13):1988-1996. PubMed ID: 36151968 [TBL] [Abstract][Full Text] [Related]
17. Perceptions about supervised injection facilities among people who inject drugs in Philadelphia. Harris RE; Richardson J; Frasso R; Anderson ED Int J Drug Policy; 2018 Feb; 52():56-61. PubMed ID: 29241143 [TBL] [Abstract][Full Text] [Related]
18. High willingness to use drug consumption rooms among people who inject drugs in Scotland: findings from a national bio-behavioural survey among people who inject drugs. Trayner KMA; Palmateer NE; Hutchinson SJ; Goldberg DJ; Shepherd SJ; Gunson RN; Tweed EJ; Priyadarshi S; Sumnall H; Atkinson A; McAuley A Int J Drug Policy; 2021 Apr; 90():102731. PubMed ID: 32331859 [TBL] [Abstract][Full Text] [Related]
19. Gaps in hepatitis C virus prevention and care for HIV-hepatitis C virus co-infected people who inject drugs in Canada. Lanièce Delaunay C; Maheu-Giroux M; Marathe G; Saeed S; Martel-Laferrière V; Cooper CL; Walmsley S; Cox J; Wong A; Klein MB; Int J Drug Policy; 2022 May; 103():103627. PubMed ID: 35218989 [TBL] [Abstract][Full Text] [Related]
20. Prevalence and associates of non-fatal overdose among people who inject drugs in Saveh, Iran. Armoon B; Griffiths MD; Bayani A; Mohammadi R; Ahounbar E Addict Sci Clin Pract; 2022 Aug; 17(1):42. PubMed ID: 35927753 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]